Fig. 2From: Current trends and challenges in cancer management and therapy using designer nanomaterialsGraphical illustration of passive and active drug targeting strategies. In passive targeting, the nanocarriers pass through the leaky walls and accumulate at the tumor site by the enhanced permeability and retention (EPR) effect. Active targeting can be achieved using specific ligands that bind to the receptors on the tumor cellsBack to article page